Explore the next generation of label-free 3D organoid imaging with Tomocube HT-X1 MAX.
Tomocube is introducing HT-X1 MAX, an innovative holotomography imaging platform designed to bring 3D high-content analysis to mature organoids, supporting the development of organoid-based New Approach Methodologies (NAMs) for drug discovery.
Join the official launch webinar on November 17, 2026, to discover how HT-X1 MAX enables researchers to visualize and quantitatively analyze intact, living organoids without fluorescent labeling.
During the webinar, participants will explore:
Label-free 3D imaging: Investigate the internal architecture of mature organoids up to 500 µm in depth.
Longitudinal analysis: Monitor the same organoids over multiple days to generate detailed dose- and time-response profiles.
Quantitative insights: Use nucleus counting and dry mass measurements to help distinguish cytotoxic from cytostatic drug effects.
The session will also introduce the operating principles of HT-X1 MAX, present experimental imaging data from live organoids, and highlight applications ranging from drug response studies to long-term organoid monitoring.
Speaker: Junhyung Park, Head of Imaging Team and Product Manager for HT-X1 MAX at Tomocube.
Webinar Details
Date: Tuesday, November 17, 2026 European session: 10:00 AM CET Format: Online webinar, followed by a live Q&A session
Discover how HT-X1 MAX can advance your organoid research and drug discovery workflows.
Discover Tomocube HT-X1 MAX: Join the Launch Webinar on November 17
Online Webinar - Presentation
Tuesday 17 November 2026 - 10:00 to 11:00
Explore the next generation of label-free 3D organoid imaging with Tomocube HT-X1 MAX.
Tomocube is introducing HT-X1 MAX, an innovative holotomography imaging platform designed to bring 3D high-content analysis to mature organoids, supporting the development of organoid-based New Approach Methodologies (NAMs) for drug discovery.
Join the official launch webinar on November 17, 2026, to discover how HT-X1 MAX enables researchers to visualize and quantitatively analyze intact, living organoids without fluorescent labeling.
During the webinar, participants will explore:
Label-free 3D imaging: Investigate the internal architecture of mature organoids up to 500 µm in depth.
Longitudinal analysis: Monitor the same organoids over multiple days to generate detailed dose- and time-response profiles.
Quantitative insights: Use nucleus counting and dry mass measurements to help distinguish cytotoxic from cytostatic drug effects.
The session will also introduce the operating principles of HT-X1 MAX, present experimental imaging data from live organoids, and highlight applications ranging from drug response studies to long-term organoid monitoring.
Speaker: Junhyung Park, Head of Imaging Team and Product Manager for HT-X1 MAX at Tomocube.
Webinar Details
Date: Tuesday, November 17, 2026
European session: 10:00 AM CET
Format: Online webinar, followed by a live Q&A session
Discover how HT-X1 MAX can advance your organoid research and drug discovery workflows.
Related products
HT-X1™ MAX
Partner
Tomocube, Inc
Related categories
Holotomographic Microscopy